The newly established clinic in Uppsala will continue the work of the OMF-Funded MultiCenter Collaborative Study on COVID to ME/CFS progression.
The clinic provides an opportunity to continue studying the disease process as it develops, and hopefully better understand ME/CFS. A subset of the previously critically ill patients will be monitored for disease progression over time alongside non-critically ill Long Covid patients who will also visit the clinic for continuing symptoms.
As with the previous study investigators will use genomics, proteomics, metabolomics, and immunology to recover as many immune cells as possible, and to characterize their evolution to ME/CFS. Furthermore, we are studying the plasma and cerebrospinal fluid (CSF) to identify proteins and large molecules (e.g., antibodies) as well as small molecules that appear or disappear in association with the development of ME/CFS.
Study A:
Study B: